Filing Details
- Accession Number:
- 0001144204-13-057499
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-10-29 19:31:26
- Reporting Period:
- 2013-07-31
- Filing Date:
- 2013-10-29
- Accepted Time:
- 2013-10-29 19:31:26
- Original Submission Date:
- 2013-10-28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100397 | Advaxis Inc. | ADXS | Pharmaceutical Preparations (2834) | 841521955 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376847 | Daniel O'connor | 305 College Road East Princeton NJ 08540 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-31 | 3,439 | $4.24 | 40,539 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2013-08-31 | 4,704 | $3.10 | 45,243 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2013-09-30 | 2,593 | $5.62 | 47,836 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2013-10-24 | 13,500 | $4.00 | 61,336 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Footnotes
- Represents earned but unissued post-split shares beneficially held by the reporting person and inadvertently omitted from the reporting person's original Form 4. The reporting person received these shares in lieu of cash compensation. Price reflects the average monthly closing price used to calculate the amount of shares earned. Such shares have been earned by the reporting person but not yet issued by the issuer.
- Previously reported on original Form 4. Voluntarily purchased with cash portion of transaction bonus plus additional personal funds.
- Amount reported on original Form 4 in this column after acquisition of comon stock inadvertently excluded 80 shares beneficially held by the reporting person. This amendment corrects that technical error.
Billionaire Hedge Funds
